Skip to main content

The context you need, when you need it

When news breaks, you need to understand what actually matters — and what to do about it. At Vox, our mission to help you make sense of the world has never been more vital. But we can’t do it on our own.

We rely on readers like you to fund our journalism. Will you support our work and become a Vox Member today?

Join now

Square tells investors that 2016 is going better than expected

More business from bigger merchants has helped.

Drew Angerer / Getty
Jason Del Rey
Jason Del Rey has been a business journalist for 15 years and has covered Amazon, Walmart, and the e-commerce industry for the last decade. He was a senior correspondent at Vox.

Square today unveiled better-than-expected financial results for the third quarter and improved its forecast for the rest of the year. Investors seemed to like the news, sending the stock up as much as 5 percent in after-hours trading.

The payments and small-business software company posted a smaller loss than expected, excluding one-time expenses, and revenue of $439 million that beat estimates of $431 million.

Additionally, Square raised its guidance for the full calendar year for net revenue and adjusted revenue, which excludes the impact of its Starbucks payment-processing relationship, which is ending soon.

The company also said that adjusted Ebitda, a profitability metric that does not take into account the expense of stock-based compensation, was going to be bigger than initially forecast. Square has been selling more products to existing payments customers, which has helped with profitability, since the customer acquisition costs on that extra revenue are typically low.

In a call with reporters, Square CFO Sarah Friar highlighted strong revenue growth among larger merchants as one positive trend boosting the core payments processing business. Forty-three percent of transactions that flow through Square’s payment pipes now come from businesses with annual sales of more than $125,000. That’s up from 37 percent in the same quarter last year.

Square’s merchant lending business, Square Capital, handed out $208 million in loans in the quarter, an increase of about 70 percent over last year and a 10 percent bump over the last quarter. Square recently opened up its lending business to non-Square merchants.

The lending business, and other non-core businesses such as Caviar restaurant delivery and software subscriptions, are crucial to Square’s future success. They both help to differentiate Square from payments industry competitors and also boast a combined gross margin of 65 percent.

This article originally appeared on Recode.net.

More in Technology

Podcasts
Are humanoid robots all hype?Are humanoid robots all hype?
Podcast
Podcasts

AI is making them better — but they’re not going to be doing your chores anytime soon.

By Avishay Artsy and Sean Rameswaram
Future Perfect
The old tech that could help stop the next airborne pandemicThe old tech that could help stop the next airborne pandemic
Future Perfect

Glycol vapors, explained.

By Shayna Korol
Future Perfect
Elon Musk could lose his case against OpenAI — and still get what he wantsElon Musk could lose his case against OpenAI — and still get what he wants
Future Perfect

It’s not about who wins. It’s about the dirty laundry you air along the way.

By Sara Herschander
Life
Why banning kids from AI isn’t the answerWhy banning kids from AI isn’t the answer
Life

What kids really need in the age of artificial intelligence.

By Anna North
Culture
Anthropic owes authors $1.5B for pirating work — but the claims process is a Kafkaesque messAnthropic owes authors $1.5B for pirating work — but the claims process is a Kafkaesque mess
Culture

“Your AI monster ate all our work. Now you’re trying to pay us off with this piece of garbage that doesn’t work.”

By Constance Grady
Future Perfect
Some deaf children are hearing again because of a new gene therapySome deaf children are hearing again because of a new gene therapy
Future Perfect

A medical field that almost died is quietly fixing one disease at a time.

By Bryan Walsh